SLC4A11 Knockout HCT 116 Cell Line
Cat.No.:
EDC08649
Species:
Human
Cell Name:
HCT 116
Gene:
SLC4A11
Gene ID:
83959
Size:
1×10⁶cells
SLC4A11 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08649 |
|---|---|
| Product Name | SLC4A11 Knockout HCT 116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC4A11 |
| NCBI Gene ID | |
| Gene Synonyms | BTR1|CDPD1|CHED|CHED2|NABC1|dJ794I6.2 |
| Summary |
This gene encodes a voltage-regulated, electrogenic sodium-coupled borate cotransporter that is essential for borate homeostasis, cell growth and cell proliferation. Mutations in this gene have been associated with a number of endothelial corneal dystrophies including recessive corneal endothelial dystrophy 2, corneal dystrophy and perceptive deafness, and Fuchs endothelial corneal dystrophy. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Mar 2010]
|
| Associated Diseases | Colorectal Carcinoma |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC4A11 function, SLC4A11 Knockout HCT 116 Cell Line or SLC4A11 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC4A11 (NaBC1)'s role in sodium-borate cotransport, ammonia transport, or its emerging functions in mitochondrial uncoupling and corneal endothelial dystrophy. The Knockout line is the standard tool for asking whether SLC4A11 is required for these activities — SLC4A11 is genetically linked to congenital hereditary endothelial dystrophy 2 (CHED2), Harboyan syndrome, and Fuchs endothelial corneal dystrophy. Overexpression is useful for studying disease-associated SLC4A11 mutations or for testing transport activity in heterologous systems.
For SLC4A11 research, the EDITGENE Knockout in HCT 116 enables mechanistic studies of NH₃/H⁺ transport and emerging mitochondrial functions, though corneal endothelial physiology requires corneal endothelial cell models. Rescue with wild-type, transport-deficient, or CHED2-associated mutant SLC4A11 is the standard approach for genotype-function correlation studies and mechanistic dissection.
What are the application scenarios for this model?
Primary applications:
• Transport activity assays: ammonia transport (NH₃/H⁺) and borate transport assays to characterize SLC4A11 substrate handling.
• Mitochondrial function: Seahorse OCR/ECAR measurements and mitochondrial uncoupling assessment given SLC4A11's reported inner mitochondrial membrane functions.
• CHED2/Harboyan syndrome modeling: rescue with disease-associated SLC4A11 variants for genotype-function correlation in a controlled background.
• Corneal endothelial-relevant biochemistry: SLC4A11 substrate handling in HCT 116 background, complementing physiological studies in corneal endothelial models.
EDITGENE recommends this model for researchers investigating SLC4A11 transporter biology and corneal endothelial dystrophy disease mechanisms.
Is this SLC4A11 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. SLC4A11 rescue experiments require attention to membrane targeting and CHED2 disease biology:
• Construct design: use a codon-modified SLC4A11 sequence with a small C-terminal tag (FLAG, HA). SLC4A11 has 14 transmembrane domains in the SLC4 family architecture — N-terminal tags must not disrupt membrane topology.
• Disease mutation rescue: CHED2-associated mutations (e.g., R109H, G583R) and Harboyan syndrome variants enable comprehensive disease genotype-function correlation.
• Surface localization validation: many CHED2 mutations cause ER retention rather than transport defects — surface biotinylation distinguishes trafficking from transport defects.
• Functional readout: rescue should restore NH₃/H⁺ transport activity measured by intracellular pH dynamics.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.